Amgen (AMGN) Outlines Growth Strategy Through 2030
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Amgen (AMGN) PT Raised to $280 at Jefferies
February 9, 2022 7:40 AM ESTJefferies analyst Michael Yee raised the price target on Amgen (NASDAQ: AMGN) to $280.00 (from $266.00) while maintaining a Buy rating.
The analyst commented, "Much can happen in a decade, but we built a calculator model to back into assumptions for 2030 (Ex 1). The... More



